Humana Weighing Drug Purchasing Change With PBM “Strategic Review”
This article was originally published in The Pink Sheet Daily
Executive Summary
The insurer is considering strategic options for its internal PBM, which manages more than 300 million drug claims for more than 9 million individuals, mainly in the Medicare space.
You may also be interested in...
Aetna/Humana Merger Would Create Fourth-Largest PBM
Strategic refocusing of the in-house PBM likely won't come until after contract with CVS expires in 2019, however.
OptumRx To Be ‘Competitive Force’ In PBM Industry With Catamaran Buy
The merger of UnitedHealth Group’s pharmacy benefit manager OptumRx with Catamaran could give the combined firm greater pricing leverage as it becomes one of the industry's giants, along with CVS Health’s Caremark and Express Scripts.
Cigna Retains Formulary Management Control Under Contract With PBM Catamaran
Under the 10-year contract, Catamaran will bring its “leading technology and service platform” to enhance operations of Cigna’s internal PBM. The deal is also expected to bolster Cigna’s drug purchasing power and help lower costs.